These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4148472)

  • 1. Psychological studies of longer range L-DOPA therapy in Parkinsonism.
    Riklan M; Halgin R; Maskin M; Weissman D
    J Nerv Ment Dis; 1973 Dec; 157(6):452-64. PubMed ID: 4148472
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive and perceptual effects of long-range L-dopa therapy in Parkinsonism.
    Hamel AR; Riklan M
    J Clin Psychol; 1975 Apr; 31(2):321-3. PubMed ID: 1133201
    [No Abstract]   [Full Text] [Related]  

  • 3. An L-dopa paradox: bipolar behavioral alterations.
    Riklan M
    J Am Geriatr Soc; 1972 Dec; 20(12):572-5. PubMed ID: 4639420
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 5. Emotional functions in short-term vs. long-term L-Dopa therapy in Parkinsonism.
    Maskin MB; Riklan M; Chabot D
    J Clin Psychol; 1973 Oct; 29(4):493-5. PubMed ID: 4148857
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of "short-term" versus "long-term" L-Dopa therapy in parkinsonism on critical flicker frequency.
    Maskin MB; Riklan M; Chabot D
    Percept Mot Skills; 1974 Apr; 38(2):455-8. PubMed ID: 4363091
    [No Abstract]   [Full Text] [Related]  

  • 7. Does levodopa alter depression and psychopathology in Parkinsonism patients?
    Marsh GG; Markham CH
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):925-35. PubMed ID: 4149286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa's awakening effect on patients with Parkinsonism.
    Marsh GG; Markham CM; Ansel R
    J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):209-18. PubMed ID: 4398342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-dopa for parkinsonism.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
    [No Abstract]   [Full Text] [Related]  

  • 10. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF; Chase TN
    Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa effects on motor and "central programming" deficits in Parkinsonism.
    Horne DJ
    Psychopharmacologia; 1974 Apr; 36(2):175-80. PubMed ID: 4407693
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric aspects in Parkinsonism treated with L-dopa.
    Damãsio AR; Lobo-Antunes J; Macedo C
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):502-7. PubMed ID: 5127432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of L-dopa on individual symptoms of parkinsonism.
    Boshes B; Blonsky ER; Arbit J; Klein K
    Trans Am Neurol Assoc; 1969; 94():229-31. PubMed ID: 5374443
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-dopa treatment of parkinsonism].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewicz E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic uses and side effects of L-dopa.
    Boshes B
    Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
    Kuran W
    Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
    Almici GM; Sbarbaro V
    Minerva Med; 1974 Feb; 65(8):398-401. PubMed ID: 4820722
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
    Jacobi P; Schneider E; Gundelsheimer W; Fischer PA
    Nervenarzt; 1974 Nov; 45(11):588-94. PubMed ID: 4453348
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral effects of l-dopa in man.
    Goodwin FK
    Semin Psychiatry; 1971 Nov; 3(4):477-92. PubMed ID: 5173049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.